Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: Results of first human Phase I trial

被引：2
|
作者：
Heller, R.
DeConti, R.
Messina, J.
Andrews, S.
Urbas, P.
Ugen, K.
Puleo, C.
Sondak, V.
Riker, A.
Daud, A.
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Univ S Florida, Ctr Mol Delivey, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL USA
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70345-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
340
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] First human phase I trial of plasmid IL-12 electro, gene therapy in patients with malignant melanoma.
    Daud, AI
    DeConti, RC
    Messina, JL
    Urbas, PA
    Andrews, S
    Ugen, KE
    Puleo, CA
    Sondak, VK
    Riker, AI
    Heller, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9119S
  • [2] Plasmid IL-12 electroporation in melanoma
    Cha, Edward
    Daud, Adil
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (11) : 1734 - 1738
  • [3] Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
    Daud, Adil I.
    DeConti, Ronald C.
    Andrews, Stephanie
    Urbas, Patricia
    Riker, Adam I.
    Sondak, Vernon K.
    Munster, Pamela N.
    Sullivan, Daniel M.
    Ugen, Kenneth E.
    Messina, Jane L.
    Heller, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5896 - 5903
  • [4] Intratumoral injection of IL-12 plasmid DNA - results of a phase I/IB clinical trial
    Mahvi, D. M.
    Henry, M. B.
    Albertini, M. R.
    Weber, S.
    Meredith, K.
    Schalch, H.
    Rakhmilevich, A.
    Hank, J.
    Sondel, P.
    CANCER GENE THERAPY, 2007, 14 (08) : 717 - 723
  • [5] Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial
    D M Mahvi
    M B Henry
    M R Albertini
    S Weber
    K Meredith
    H Schalch
    A Rakhmilevich
    J Hank
    P Sondel
    Cancer Gene Therapy, 2007, 14 : 717 - 723
  • [6] Systemic immune responses induced by intratumoral plasmid IL-12 electroporation in patients with melanoma.
    Cha, E.
    Daud, A.
    McNeel, D. G.
    Heller, R.
    Fong, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Phase I trial of IL-2 plasmid DNA with electroporation in metastatic melanoma
    Richards, J. M.
    Gonzalez, R.
    Schwarzenberger, P.
    Whitman, E.
    Stardal, K.
    Westhoff, C.
    Moss, R.
    Strause, L.
    Selk, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study
    Y Sun
    K Jurgovsky
    P Möller
    S Alijagic
    T Dorbic
    J Georgieva
    B Wittig
    D Schadendorf
    Gene Therapy, 1998, 5 : 481 - 490
  • [9] Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study
    Sun, Y
    Jurgovsky, K
    Moller, P
    Alijagic, S
    Dorbic, T
    Georgieva, J
    Wittig, B
    Schadendorf, D
    GENE THERAPY, 1998, 5 (04) : 481 - 490
  • [10] Treatment of tumor metastases with recombinant plasmid DNA expressing human IL-12: A phase I clinical trial
    Henry, MB
    Meredith, KL
    Weber, S
    Albertini, MR
    Mahvi, DM
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 89 - 89
12345